Serotonin 1A Receptor Hippocampal Binding Potential in Depression and Reported Childhood Adversity
Overview
Authors
Affiliations
Background: Reported childhood adversity (CA) is associated with development of depression in adulthood and predicts a more severe course of illness. Although elevated serotonin 1A receptor (5-HTR) binding potential, especially in the raphe nuclei, has been shown to be a trait associated with major depression, we did not replicate this finding in an independent sample using the partial agonist positron emission tomography tracer [C]CUMI-101. Evidence suggests that CA can induce long-lasting changes in expression of 5-HTR, and thus, a history of CA may explain the disparate findings.
Methods: Following up on our initial report, 28 unmedicated participants in a current depressive episode (bipolar = 16, unipolar = 12) and 19 non-depressed healthy volunteers (HVs) underwent [C]CUMI-101 imaging to quantify 5-HTR binding potential. Participants in a depressive episode were stratified into mild/moderate and severe CA groups via the Childhood Trauma Questionnaire. We hypothesized higher hippocampal and raphe nuclei 5-HTR with severe CA compared with mild/moderate CA and HVs.
Results: There was a group-by-region effect ( = 0.011) when considering HV, depressive episode mild/moderate CA, and depressive episode severe CA groups, driven by significantly higher hippocampal 5-HTR binding potential in participants in a depressive episode with severe CA relative to HVs ( = 0.019). Contrary to our hypothesis, no significant binding potential differences were detected in the raphe nuclei ( > 0.05).
Conclusions: With replication in larger samples, elevated hippocampal 5-HTR binding potential may serve as a promising biomarker through which to investigate the neurobiological link between CA and depression.
Brain serotonin, oxytocin, and their interaction: Relevance for eating disorders.
Ismaylova E, Nemoda Z, Booij L J Psychopharmacol. 2025; 39(3):187-200.
PMID: 39745000 PMC: 11843796. DOI: 10.1177/02698811241309617.
Wu Y, Deng J, Ma J, Chen Y, Hu N, Hao S Adv Sci (Weinh). 2024; 11(33):e2402152.
PMID: 38946585 PMC: 11434213. DOI: 10.1002/advs.202402152.
Functional Dimerization of Serotonin Receptors: Role in Health and Depressive Disorders.
Mitroshina E, Marasanova E, Vedunova M Int J Mol Sci. 2023; 24(22).
PMID: 38003611 PMC: 10671093. DOI: 10.3390/ijms242216416.
Intersection of Sex and Depression: Pathogenesis, Presentation, and Treatments.
Frohman D, Nnah K, Tsirka S Handb Exp Pharmacol. 2023; 282:163-180.
PMID: 37439845 PMC: 11519624. DOI: 10.1007/164_2023_670.
Bartlett E, Zanderigo F, Stanley B, Choo T, Galfalvy H, Pantazatos S Eur Neuropsychopharmacol. 2023; 70:1-13.
PMID: 36780841 PMC: 10121874. DOI: 10.1016/j.euroneuro.2023.01.006.